Healthy Returns: First Ozempic generics in Canada will be a test case for Novo Nordisk

The introduction of generic versions of Ozempic in Canada may lead to a decline in international revenue for Novo Nordisk's semaglutide. This marks a significant test case for the company. The generics will likely impact Novo Nordisk's revenue from Ozempic and Wegovy.